Stock Scorecard
Stock Summary for Quest Diagnostics Inc (DGX) - $196.20 as of 5/29/2026 10:36:46 AM EST
Total Score
11 out of 30
Safety Score
50 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for DGX
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for DGX
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for DGX
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for DGX
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for DGX (50 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 9 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 4 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 6 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for DGX
Financial Details for DGX
Company Overview |
|
|---|---|
| Ticker | DGX |
| Company Name | Quest Diagnostics Inc |
| Country | N/A |
| Description | Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 3/31/2026 |
| Next Earnings Date | 7/21/2026 |
Stock Price History |
|
| Last Day Price | 196.20 |
| Price 4 Years Ago | 145.99 |
| Last Day Price Updated | 5/29/2026 10:36:46 AM EST |
| Last Day Volume | 653,708 |
| Average Daily Volume | 957,272 |
| 52-Week High | 212.58 |
| 52-Week Low | 162.47 |
| Last Price to 52 Week Low | 20.76% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 27.54 |
| Sector PE | 66.00 |
| 5-Year Average PE | 28.35 |
| Free Cash Flow Ratio | 55.27 |
| Industry Free Cash Flow Ratio | 51.51 |
| Sector Free Cash Flow Ratio | 34.59 |
| Current Ratio Most Recent Quarter | 1.18 |
| Total Cash Per Share | 3.55 |
| Book Value Per Share Most Recent Quarter | 66.36 |
| Price to Book Ratio | 2.91 |
| Industry Price to Book Ratio | 137.77 |
| Sector Price to Book Ratio | 23.00 |
| Price to Sales Ratio Twelve Trailing Months | 1.92 |
| Industry Price to Sales Ratio Twelve Trailing Months | 3.88 |
| Sector Price to Sales Ratio Twelve Trailing Months | 5.25 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 110,696,000 |
| Market Capitalization | 21,718,555,200 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 7/8/2026 |
| Previous Dividend Amount | 0.8600 |
| Current Dividend Amount | 0.8600 |
| Total Years Dividend Increasing |
|
| Trailing Annual Dividend Rate | 3.26 |
| Trailing Annual Dividend Yield | 1.68% |
| Forward Annual Dividend Rate | 3.44 |
| Forward Annual Dividend Yield | 1.77% |
| 5-Year Dividend Payments Count | 21 |
| 3-Year Average Dividend Yield | 1.83% |
| 5-Year Average Dividend Yield | 1.94% |
| 1-Year Dividend Growth Rate Percentage | 9.21% |
| 3-Year Dividend Growth Rate Percentage | 4.50% |
| 5-Year Dividend Growth Rate Percentage | 7.25% |
| All-Time Dividend Growth Rate Percentage | 10.67% |
| Dividend Payout Ratio | 35.98% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 15.50% |
| Annual Earnings Growth | 13.89% |
| Reported EPS 12 Trailing Months | 9.06 |
| Reported EPS Past Year | 2.50 |
| Reported EPS Prior Year | 9.85 |
| Net Income Twelve Trailing Months | 1,024,000,000 |
| Net Income Past Year | 992,000,000 |
| Net Income Prior Year | 871,000,000 |
| Quarterly Revenue Growth YOY | 9.20% |
| 5-Year Revenue Growth | 3.18% |
| Operating Margin Twelve Trailing Months | 14.20% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 393,000,000 |
| Total Cash Past Year | 420,000,000 |
| Total Cash Prior Year | 549,000,000 |
| Net Cash Position Most Recent Quarter | -4,762,000,000 |
| Net Cash Position Past Year | -4,747,000,000 |
| Long Term Debt Past Year | 5,167,000,000 |
| Long Term Debt Prior Year | 5,615,000,000 |
| Total Debt Most Recent Quarter | 5,155,000,000 |
| Equity to Debt Ratio Past Year | 0.58 |
| Equity to Debt Ratio Most Recent Quarter | 0.59 |
| Total Stockholder Equity Past Year | 7,170,000,000 |
| Total Stockholder Equity Prior Year | 6,778,000,000 |
| Total Stockholder Equity Most Recent Quarter | 7,366,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 1,326,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 11.98 |
| Free Cash Flow Past Year | 1,359,000,000 |
| Free Cash Flow Prior Year | 909,000,000 |
Options |
|
| Put/Call Ratio | 0.19 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.00 |
| MACD Signal | 0.00 |
| 20-Day Bollinger Lower Band | 0.00 |
| 20-Day Bollinger Middle Band | 0.00 |
| 20-Day Bollinger Upper Band | 0.00 |
| Beta | 0.60 |
| RSI | 0.00 |
| 50-Day SMA | 0.00 |
| 150-Day SMA | 0.00 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 5/27/2026 9:25:57 PM EST |